@article{04b19bd64f304efd81de927ebe2bdeaf,
title = "An appropriate challenge for the nuclear cardiology community",
author = "Miller, {Todd D.} and Hendel, {Robert C.}",
note = "Funding Information: Dr Miller receives research grants from King Pharmaceuticals, KAI Pharmaceuticals, TherOx, TargeGen, Radiant Medical, and Bristol-Myers Squibb and has consulting agreements with GE Healthcare and The Medicines Company. Dr Hendel receives research grants from GE Healthcare and Astellas Pharma and has consulting agreements with GE Healthcare, Astellas Pharma, and Adenosine Therapeutics.",
year = "2008",
month = may,
doi = "10.1016/j.nuclcard.2008.03.002",
language = "English (US)",
volume = "15",
pages = "305--307",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",
number = "3",
}